S. Burchett

发表

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.

L. Corey, L. Corey, L. Vontver, 1991, The New England journal of medicine.

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children

S. Spector, F. Aweeka, E. Capparelli, 2007, AIDS.

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents

M. Hughes, W. Borkowsky, S. Spector, 2003, The Lancet.

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).

L. Mofenson, C. Fletcher, M. Fowler, 2000, The Journal of infectious diseases.

Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.

S. Sheu, L. Ramirez-Avila, U. Degirolami, 2014, The Pediatric infectious disease journal.

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

J. Bale, S. Spector, S. Soong, 1996, The Pediatric infectious disease journal.

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.

W. Borkowsky, L. Mofenson, S. Spector, 2001, The Journal of infectious diseases.

Effect of Cytomegalovirus Co-Infection on Normalization of Selected T-Cell Subsets in Children with Perinatally Acquired HIV Infection Treated with Combination Antiretroviral Therapy

G. Montepiedra, A. Weinberg, A. Kovacs, 2015, PloS one.

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

E. Capparelli, E. Joao, S. Burchett, 2020, Antimicrobial Agents and Chemotherapy.

The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children.

E. Orav, T. Miller, S. Gorbach, 2001, Pediatrics.

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

S. Spector, S. Nichols, T. Yao, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Production of Lymphotoxin and Tumor Necrosis Factor by Human Neonatal Mononuclear Cells

A. Ammann, Christopher B Wilson, J. English, 1988, Pediatric Research.

Antiretroviral Treatment of US Children With Perinatally Acquired HIV Infection: Temporal Changes in Therapy Between 1991 and 2009 and Predictors of Immunologic and Virologic Outcomes

L. Mofenson, S. Spector, G. Seage, 2011, Journal of acquired immune deficiency syndromes.

Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

N. Reiner, W. McMaster, C. Wilson, 1990, The Journal of clinical investigation.

Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents.

D. Richman, G. Seage, D. Persaud, 2014, JAMA pediatrics.

Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.

K. Puopolo, S. Permar, S. Burchett, 2011, The Journal of infectious diseases.

Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.

W. M. Weaver, Christopher B Wilson, C. Wilson, 1988, Journal of immunology.

Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis

D. Hafler, E. Thiele, S. Burchett, 1998, Journal of Neuroimmunology.

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

S. Spector, R. Kagan, S. Nichols, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diminished Interferon-γ and Lymphocyte Proliferation in Neonatal and Postpartum Primary Herpes Simplex Virus Infection

L. Corey, Christopher B Wilson, R. Ashley, 1992 .

Immunologic reconstitution following hematopoietic stem cell transplantation despite lymph node paucity in NF-κB-inducing kinase deficiency.

K. Schwarz, A. Schulz, R. Geha, 2018, The Journal of allergy and clinical immunology.

Enhanced Production of Monokines by Canine Alveolar Macrophages in Response to Endotoxin-Induced Shock

R. Jacobs, S. Burchett, D. Tabor, 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Antimicrobial-Speciﬁc Cell-Mediated Immune Reconstitution in Children with Advanced Human Immunodeﬁciency Virus Infection Receiving Highly Active Antiretroviral Therapy

L. Mofenson, A. Weinberg, A. Kovacs, 2004 .

Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts

L. Mofenson, M. Lindegren, M. Fowler, 2000 .

Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators.

W. Borkowsky, L. Mofenson, S. Spector, 2000, The Journal of infectious diseases.

Expression of HLA class II antigens and secretion of interleukin-1 by monocytes and macrophages from adults and neonates.

C. Wilson, S. Burchett, D. Brownstein, 1987, Immunology.

Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.

W. Borkowsky, S. Spector, R. Yogev, 2000, The Journal of infectious diseases.

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV

E. Barr, E. Acosta, E. Capparelli, 2018, AIDS.

Lymphocyte subsets in HIV-exposed uninfected infants and HIV-unexposed uninfected infants.

G. Siberry, W. Shearer, S. Burchett, 2017, The Journal of allergy and clinical immunology.

HIV infection in infants, children, and adolescents.

P. Pizzo, S. Burchett, 2003, Pediatrics in review.

Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents.

L. Frenkel, S. Burchett, R. Cone, 1997, Archives of pediatrics & adolescent medicine.

Rates of Hospitalization and Infection-Related Hospitalization Among Human Immunodeficiency Virus (HIV)–Exposed Uninfected Children Compared to HIV- Unexposed Uninfected Children in the United States, 2007–2016

S. Hernández-Díaz, K. Huybrechts, S. Burchett, 2020 .

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.

L. Corey, L. Vontver, Z. Brown, 1991, The New England journal of medicine.

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.

D. Powell, L. Corey, S. Plotkin, 1991, The New England journal of medicine.

Case Report of a Child after Hematopoietic Cell Transplantation with Acute Aspergillus Tracheobronchitis as a Cause for Respiratory Failure

K. Madden, S. Burchett, C. Duncan, 2016, Case reports in pediatrics.

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection

S. Soong, D. Powell, L. Corey, 1992 .

Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

D. Powell, L. Corey, R. Jacobs, 1996, The Journal of infectious diseases.

Predictors of morbidity and mortality in neonates with herpes simplex virus infections

D. Powell, L. Corey, C. Sumaya, 1991, The New England journal of medicine.

Risk of congenital cytomegalovirus infection among HIV‐exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy

E. Leister, Meei-Li W Huang, K. Jerome, 2016, Journal of medical virology.

Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth.

L. Corey, Z. Brown, S. Berry, 1992, The Journal of clinical investigation.

Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2011, Journal of acquired immune deficiency syndromes.

Pharmacokinetic disposition of zidovudine during pregnancy.

L. Corey, D. H. Watts, R. Coombs, 1991, The Journal of infectious diseases.

Impact of pregnancy on abacavir pharmacokinetics

S. Spector, Chengcheng Hu, J. Connor, 2006, AIDS.

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

L. Mofenson, J. Hitti, J. Unadkat, 2004, The Journal of infectious diseases.

Single-Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1

S. Blanchard, J. Rodman, J. Shenep, 2000, Antimicrobial Agents and Chemotherapy.

Reconstitution of Virus-Specific CD4 Proliferative Responses in Pediatric HIV-1 Infection 1

B. Walker, M. Feeney, P. Goulder, 2003, The Journal of Immunology.

Comprehensive Screening Reveals Strong and Broadly Directed Human Immunodeficiency Virus Type 1-Specific CD8 Responses in Perinatally Infected Children

B. Walker, M. Feeney, P. Goulder, 2003, Journal of Virology.

Paediatric HIV infection: correlates of protective immunity and global perspectives in prevention and management.

P. Goulder, P. Jeena, S. Burchett, 2001, British medical bulletin.

International perspectives, progress, and future challenges of paediatric HIV infection

P. Goulder, P. Jeena, S. Burchett, 2007, The Lancet.

Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children.

M. Cowles, M. Hughes, J. Lindsey, 2000, The Journal of infectious diseases.

Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy.

L. Mofenson, V. Carey, A. Weinberg, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reduced lopinavir exposure during pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2006, AIDS.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

D. Hawkins, M. V. van Kasteren, K. Kabeya, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women

L. Mofenson, E. Capparelli, S. Burchett, 2015, Journal of acquired immune deficiency syndromes.

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

L. Kalish, T. Quinn, J. Lew, 1999, The New England journal of medicine.

Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV

E. Barr, E. Acosta, M. Purswani, 2018, AIDS.

Raltegravir Pharmacokinetics During Pregnancy

F. Aweeka, D. H. Watts, E. Capparelli, 2014, Journal of acquired immune deficiency syndromes.

Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2010, Journal of acquired immune deficiency syndromes.

Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women.

J. Hughes, D. H. Watts, J. Hitti, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1

Philip J. R. Goulder, Todd M. Allen, Simon Mallal, 2005, The Journal of Immunology.

Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease

A. Bousvaros, M. Gregas, D. Jacobson, 2009, The American Journal of Gastroenterology.

Immunogenicity and Tolerability to Human Papillomavirus-like Particle Vaccine in Girls and Young Women with Inflammatory Bowel Disease

A. Bousvaros, D. Jacobson, Rebecca G. Carey, 2013, Inflammatory bowel diseases.

Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus.

K. Mcintosh, D. Zaknun, P. Chatis, 1996, The Pediatric infectious disease journal.

The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy

Mindy S Lo, L. Lehmann, Grace M. Lee, 2013, Pediatric transplantation.

D. Powell, L. Corey, R. Jacobs, 1996, The Journal of infectious diseases.

Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants

W. Borkowsky, L. Mofenson, Hulin Wu, 1999, Journal of Virology.

Septic Episodes in a Premature Infant After In Utero Exposure to Rituximab

S. Burchett, S. Çataltepe, Oreofe O. Odejide, 2017, Pediatrics.

Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation.

B. Walker, E. Holmes, C. Brander, 2001, Immunology letters.

Response Emergence of a Variant-Specific CTL HIV-1 Viral Escape in Infancy Followed by Altfeld ,

Todd M. Allen, M. Altfeld, B. Walker, 2005 .

Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children

E. Rosenberg, M. Altfeld, B. Walker, 2000, The Journal of experimental medicine.

Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection

S. Spector, E. Barr, S. Nichols, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4+ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy Interruption

S. Spector, G. Seage, G. Siberry, 2011, Journal of acquired immune deficiency syndromes.

Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus–Infected Youth

Paige L. Williams, M. Purswani, P. Williams, 2017, JAMA pediatrics.

Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease

O. King, A. Moscicki, S. Spector, 2020, Metabolomics.

Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease. A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children.

D. Fuchs, K. Mcintosh, J. Orav, 1997, The Journal of pediatrics.

Immunologic and Virologic Factors Associated with Hospitalization in HIV-Exposed, Uninfected Infants in the United States.

A. Weinberg, S. Burchett, K. Patel, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.

W. Bellini, M. Purswani, G. Siberry, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.

G. Montepiedra, L. Mofenson, V. Carey, 2005, The Journal of infectious diseases.

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

M. McNichols, S. Bewley, W. Borkowsky, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children

B. Sadler, R. Yogev, J. Unadkat, 1999, Antimicrobial Agents and Chemotherapy.

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.

S. Spector, R. Yogev, G. Siberry, 2012, The Journal of infectious diseases.

Lopinavir Exposure With an Increased Dose During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2008, Journal of acquired immune deficiency syndromes.

Neurodevelopment of HIV-Exposed Uninfected Infants Born to Women with Perinatally-Acquired HIV in the United States.

Paige L. Williams, R. Sperling, P. Williams, 2020, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy

D. H. Watts, S. Burchett, T. Cressey, 2013, Journal of acquired immune deficiency syndromes.

Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.

M. Cowles, D. H. Watts, L. Frenkel, 1997, The Journal of infectious diseases.

A Digital Platform to Support HIV Case Management for Youth and Young Adults: Mixed Methods Feasibility Study

Julia S. Fuller, D. Swendeman, J. Jackson, 2022, JMIR formative research.

Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1.

T. Schacker, L. Corey, D. H. Watts, 1997, American journal of obstetrics and gynecology.

Rates of Hospitalization and Infection-Related Hospitalization Among HIV-Exposed Uninfected Children Compared to HIV-Unexposed Uninfected Children in the United States, 2007-2016.

S. Hernández-Díaz, K. Huybrechts, S. Burchett, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV exposed, uninfected youth.

Man Wai Ng, A. Moscicki, C. Shiboski, 2019, Journal of clinical periodontology.

Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.

E. Capparelli, M. Paul, S. Burchett, 2021, AIDS.

T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children

G. Montepiedra, A. Kovacs, S. Burchett, 2012, AIDS.

Transmission of Hepatitis C Virus Through Transplanted Organs and Tissue – Kentucky and Massachusetts, 2011

S. Holmberg, Y. Khudyakov, M. Kuehnert, 2011, MMWR. Morbidity and mortality weekly report.

Evolution and transmission of stable CTL escape mutations in HIV infection

Michael Bunce, Robert Funkhouser, Christian Brander, 2001, Nature.

Prevalence of periodontal diseases in a multicenter cohort of perinatally HIV‐infected and HIV‐exposed and uninfected youth

Victor Badner, Ram Yogev, Vivian Olivera, 2017, Journal of clinical periodontology.